In addition, currently recognized GBM prognostic genes (IDH1, TP53, ATRX, NUP16, TIAM2, NEK10, and ABCA1) showed significant differences in mutation frequency between the high-risk and low-risk groups (Figure 5(b)). The gene discussed is NEK10; the disease is glioblastoma.